Physician profile
Scott Stubbs
NPI 1427032549
$1,447.95
in general payments reported to CMS, 2019-2025
15 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $19.92 · 2022: $119 · 2023: $130 · 2024: $294 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $485.36 | 2019-2024 | |
| Stryker Corporation | $280.89 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex, Aequalis Perform Reversed |
| Smith+Nephew, INC. | $222.60 | 2019 | |
| Depuy Synthes Sales INC. | $106.42 | 2022-2024 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $75.78 | 2024-2025 | |
| Medline Industries LP | $51.22 | 2024 | |
| Convatec INC. | $48.10 | 2019-2023 | |
| Pacira Therapeutics, INC. | $36.03 | 2019 | |
| Bioventus LLC | $32.81 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $27.45 | 2019 | |
| P Bar Medical LLC | $19.85 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $17.54 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.07 | 2022 | |
| Heron Therapeutics, INC. | $15.65 | 2025 | Zynrelef |
| Ferring Pharmaceuticals INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Stubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.